Winter wheat disease can be managed Jun 4, 2008
Unlike many vascular diseases that produce toxins and various compounds that gum up the vascular system of a plant and then cause wilting, Cephalosporium actually grows in the vascular tissue. The leaf symptoms of Cephalosporium stripe can occur from jointing to heading. (Mattoon Journal-Gazette, IL)
Medical Ventures' Shareholders Approve Acquisitions and Related Activities Jun 4, 2008
The company's products help doctors treat a wide range of health conditions, including vascular diseases and obesity. They include the Metricath arterial and in-stent measurement system, and PeriPatch(TM) surgical tissue and staple line reinforcement products. (CCNMatthews Press Releases)
ThromboGenics and BioInvent Report Positive Phase I Results for Anti-PlGF Cancer Therapeutic TB-403 Jun 3, 2008
About ThromboGenics ThromboGenics is a biotechnology company focused on discovery and development of biopharmaceuticals for the treatment of a range of vascular diseases. The Company has several programs in Phase II clinical development including microplasmin, which is being evaluated as a treatment for vitreoretinal disorders and as a thrombolytic agent for vascular occlusive diseases, including acute stroke. (PR Newswire)
Chemokine Therapeutics Announces Issuance of Two New U.S. Patents May 28, 2008
VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 28, 2008) - Chemokine Therapeutics Corp. (the "Company") (TSX: - ; OTCBB: - ), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases, today announced that it has been granted two U.S. Patents (No's 7,354,899 and 7,368,425) ... Patent No. 7,368,425 entitled "Cyclic Peptides for Modulating Growth of Neo-Vessels and Their Use in Therapeutic Angiogenesis" is related to the use of chemokine... (CCNMatthews Press Releases)
Women’s Committee plans health fair May 22, 2008
The Life Line Screening program, which includes non-invasive screenings for vascular diseases, will also be held from 9 a.m. to 4 p.m.. Screenings include carotid artery/stroke, abdominal aortic aneurysm, peripheral arterial disease, and osteoporosis. (Kewanee Star Courier, IL)
Half of the workforce in Indian industries overweight May 20, 2008
The study recommends imparting health education for preventing Cardio Vascular Diseases (CVD) and assess the impact of health education on controlling these diseases. The surveillance started with a baseline survey of more than 35,000 employees and their family members in 10 different industries in India in the age group of 10-69 years and a detailed risk factor survey of 20,000 randomly-selected individuals. (Economic Times)
Hospital adapts to state's aging population May 10, 2008
Endovascular neuroradiology is treatment of vascular diseases of the central nervous system and spine without using surgery. The new suite, which is equipped with a state-of-the-art neuroradiology system, takes detailed X-ray images that allow the physician to reconstruct the patient's anatomy in a three-dimensional view. (Anchorage Daily News)
Much Of The Increased Risk Of Death From Smoking Reduced Within Several Years After Quitting May 8, 2008
"Significant trends were observed with increasing years since quitting for all major cause-specific outcomes. A more rapid decline in risk after quitting smoking compared with continuing to smoke was observed in the first 5 years for vascular diseases compared with other causes.". "Much of the reduction in the excess risk for these causes of death were realized within the first 5 years for coronary heart disease and cerebrovascular disease. Sixty-one percent of the full potential benefit of... (Science Daily)
ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke Apr 9, 2008
LEUVEN, Belgium, April 9 /PRNewswire-FirstCall/ -- ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on vascular diseases, eye diseases and cancer, announces today that it has completed patient enrolment for its Phase II MITI IV study ... About ThromboGenics ThromboGenics is a biotechnology company focused on discovery and development of biopharmaceuticals for the treatment of a range of vascular diseases. (PR Newswire)
India a diabetic capital of the world Apr 8, 2008
Lifestyle related diseases like obesity, diabetes, cardio vascular diseases are afflicting India. India is also facing the old world problems of malaria, dengue, chikungunya, and diarrhoea,'' said Anthony J McMichael, a health scientist associated with the Intergovernmental Panel on Climate Change (IPCC). (NDTV.com)
Chemokine Therapeutics Announces 2007 Financial and Operating Results Apr 7, 2008
VANCOUVER, BRITISH COLUMBIA--(Marketwire - April 7, 2008) - Chemokine Therapeutics Corp. (the "Company") (TSX: - ; OTCBB: - ), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular diseases, today announced the financial and operating results of the year ended December 31, 2007. ADVERTISEMENT. (CCNMatthews Press Releases)
Tobacco claims 8 lakh lives in India every year Apr 7, 2008
It increases blood pressure, heart rate, hastens hardening of arteries causing heart attacks and vascular diseases. Some vascular diseases like TAO and Bergers disease never occur in nonsmokers and so is the case with. (Newindpress)
UK Heart Checks Could Save 2000 Lives Each Year Apr 5, 2008
A national programme to identify vulnerability to vascular diseases will prevent up to 9,500 heart attacks and strokes every year and save 2,000 lives, has been announced by UK Health Secretary Alan Johnson. Collectively, vascular diseases - heart disease, stroke, diabetes and kidney disease - affect the lives of more than four million people and kill 170,000 every year ... "We are also determined to tackle the inequalities in health, and vascular diseases are the main cause. All too often,... (Wireless Healthcare)
Health MoT for the over-40s 'will save 2000 lives a year' Apr 3, 2008
" The MoTs will check the risk people face of developing vascular diseases - those which affect the blood vessels, such as heart disease, strokes, diabetes and kidney disease. Scroll down for more... Read more... Together, they affect the lives of four million and kill 170,000 every year. The Department of Health said the screening programme, which will cost 250million a year, will also prevent 4,000 a year from developing diabetes and detect at least 25,000 cases of diabetes or kidney disease... (Daily Mail)
ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III) Apr 1, 2008
LEUVEN, Belgium, April 1 /PRNewswire-FirstCall/ -- - Trial Results Expected Mid-2008 ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on vascular diseases, eye diseases and cancer, today announces that it has completed patient enrolment for its Phase IIb MIVI III trial in the United States ... About ThromboGenics ThromboGenics is a biotechnology company focused on discovery and development of biopharmaceuticals for the treatment of a range of vascular diseases. (PR Newswire)
Woman encourages people to be heart smart Mar 16, 2008
Karen Paul was aware of vascular diseases in her family. Her mother, who died from a heart attack at age 75, warned Paul of the family s history. (Conroe Courier, TX)
Encysive Pharmaceuticals Announces Date Change for Reporting 2007 Year-End Financials Feb 22, 2008
Our research and development programs are predominantly focused on the treatment and prevention of interrelated diseases of the vascular endothelium and exploit our expertise in the area of the intravascular inflammatory process, referred to as the inflammatory cascade, and vascular diseases. To learn more about Encysive Pharmaceuticals please visit our web site. (Primezone Releases)
Stemcell transplantion a new boon for patients Feb 4, 2008
Till date, multicentric study of stem cell application by the hospital in spinal cord injury, liver cerosis and peripheral vascular diseases has proven the safety in all and efficacy in select group of patients, who otherwise have not other option of treatment at the moment, he said. The contention of ASSI was not in good taste and casting aspiration on fellow doctors and surgeons was against medical ethics, Dr J K B C Parthiban, neurosurgeon, Kovai Medical Center and Hospital, who himself is a... (Hindu)
Injuries might boost clot risk Jan 26, 2008
Lawrence estimates that the center performs 4,000 to 5,000 ultrasounds a year for patients with vascular diseases. Of particular concern, he says, is the study s questionnaire format, in which venous thrombosis patients and a control group were asked about their recollections of previous injuries. (Albany Democrat-Herald, OR)
Stroke, bone screens on Thursday Jan 16, 2008
These non-invasive, inexpensive and painless ultrasound tests help people identify their risk for stroke, vascular diseases or osteoporosis early enough for their physician to begin preventive procedures. For more information regarding the screenings or to schedule an appointment, those interested can call (877) 237-1377 or visit. (Coos Bay-North Bend The World, OR)
Lipoic acid could reduce atherosclerosis, weight gain Jan 15, 2008
reducing known risk factors for the development of atherosclerosis and other inflammatory vascular diseases in humans ... As a result, the authors concluded that lipoic acid may be a useful adjunct in the prevention and treatment of atherosclerotic vascular diseases. (EurekAlert!)
Low cancer risk for those with Down syndrome Jan 3, 2008
The basic biological mechanism, which affects blood vessel function and growth, may also underlie other so-called vascular diseases such as atherosclerosis, Folkman said. Folkman and other researchers believe people with Down produce extra endostatin naturally, but also that other genes play an important role. (MSNBC -- Health)
Cut down of fat intake, consume more vegetables Dec 30, 2007
She noted that the recent rise in non communicable diseases in the country has been as a result of the unhealthy lifestyle choices resulting in diseases such cardio vascular diseases, cancer, diabetes, obesity, mental illness and bone and muscular diseases, which are described as the greatest killers of the day. Ms Adjei said, to increase the quality of the Ghanaians diet during these festivities, fruits and vegetables should be increased in both quantity and quality to supply the vitamins,... (Ghana Web, Ghana)
What AM I? AM Is A Regulator Of Vascular System Functionality Dec 21, 2007
25, 2007) Low-density lipoprotein, a transporter of cholesterol, may also contribute to vascular diseases by a previously unidentified mechanism, according to a new report. The study reveals a link between. (Science Daily)
Small RNAs and Large DNA Viruses Dec 20, 2007
Moreover, CMV infection is a leading cause of birth defects and has been implicated in the acceleration of long-term vascular diseases such as atherosclerosis. Like infection with other herpesviruses, a primary CMV infection is followed by a lifelong persistent or latent state of the virus in the host. (New England Journal of Medicine)
ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting Dec 11, 2007
Professor Peter Verhamme, Department of Vascular Diseases, University of Leuven, who presented the results at the ASH meeting, commented: "The results from the first Phase I study with TB-402 show that this novel human monoclonal antibody is safe and well-tolerated, an important first step in the development of this new anticoagulant drug. Of equal importance, the results clearly indicate that TB-402 has the long half-life we predicted and a stable long-acting anticoagulant effect based on... (PR Newswire)
ED in Younger Men Usually Psychogenic Dec 4, 2007
We dont see much of vascular diseases, so more of the cases are a result of what is between the ears. You dont see a lot of erectile dysfunction in men under the age of 40. (Newsmax)
Erectile Dysfunction in Young Men Often Psychological Nov 27, 2007
We don t see much of vascular diseases so more of the cases are a result of what is between the ears. You don t see a lot of erectile dysfunction in men under the age of 40. (Fox News)
Arterial Vascular Disease Underdiagnosed, Undertreated In Older US Women Nov 23, 2007
(May 2, 2007) Migraines during pregnancy are strongly linked to vascular diseases, such as stroke and heart disease, according to new. (Jan. (Science Daily)
Shareholder Class Action Filed Against Micrus Endovascular Corporation by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP Nov 17, 2007
Micrus develops, manufactures, and markets implantable and disposable medical devices used in the treatment of cerebral vascular diseases. More specifically, the Complaint alleges that the Company failed to disclose and misrepresented the following material adverse facts which were known to defendants or recklessly disregarded by them: (1) that the Company was experiencing increased competition and seasonal slowing, which led to slower sales in North America; (2) that the Company was... (PR Newswire)
HEALTH NOTES / Memorable tips about forgetfulness Nov 16, 2007
A number of studies in recent years have suggested that vascular diseases heart disease and stroke may contribute to the development of AD, the severity of AD, or the development of multi-infarct dementia (also called vascular dementia). Don't smoke or abuse alcohol. (Cohasset Mariner, MA)
Looking at Glaucoma as a Systemic Disease Nov 12, 2007
Studies have found that patients with exfoliative glaucoma have a higher incidence of several other diseases, including Alzheimer's and vascular diseases. "The same genetic variation that affects the eye is probably active in all these other tissues," says Dr. Ritch. (PR Newswire)
5,000 Patients Treated With OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Now Enrolled in Real-Life Use Global Registry Nov 9, 2007
"Completing enrollment in this large registry is an important milestone in our clinical development," said Samuel Rasmussen, OrbusNeich's president and CEO. OrbusNeich designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. In addition to Genous OrbusNeich's products are stents, balloons and guiding catheters marketed under the names of Blazer(TM), R stent(TM), Sapphire(TM), Avita(TM), Avita HP(TM), SafeCut(TM), Lumina(TM) and Saffron. (PR Newswire)
ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis Inhibitors in Cell Nov 2, 2007
Desire Collen, CEO and Chairman of ThromboGenics, commented: "Today's publication in the prestigious journal Cell clearly highlights our ground-breaking research in the field of angiogenesis. The data in the Cell paper shows the potential of our novel anti-PlGF antibody, TB-403, based on its unique ability to block the development of new blood vessels, but only via mechanisms that exist in the diseased state. This mode of action, which is different from and complementary to current anti-VEGF... (PR Newswire)
* Results of mortality rate study surprise researchers Nov 1, 2007
89 times more likely to die because of vascular diseases and 1 ... 49 times more likely to die from vascular diseases. (Taipei Times, Taiwan -- World)
Contribution of cholesterol transporter to vascular disease Oct 26, 2007
Low-density lipoprotein, a transporter of cholesterol, may also contribute to vascular diseases by a previously unidentified mechanism, according to a report published online this week in EMBO reports. Low-density lipoprotein (LDL), a transporter of cholesterol, may also contribute to vascular diseases by a previously unidentified mechanism, according to a report published online this week in EMBO reports ... Vascular diseases such as thrombosis, stroke and heart attacks are associated with this... (EurekAlert!)
Erectile Dysfunction: A Harbinger of Heart Trouble Oct 6, 2007
And now a growing body of research ties erectile dysfunction to vascular diseases, such as coronary artery disease. "Erectile dysfunction is often caused by vascular disease," explained Dr. Ian Thompson, professor and chairman of the department of urology at the University of Texas Health Science Center at San Antonio. (U.S. News & World Report)
Chemokine Therapeutics Completes Patient Recruitment of CTCE-9908 Phase I/II Clinical Trial Oct 2, 2007
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Oct. 2, 2007) - Chemokine Therapeutics Corp. (the "Company") (TSX: - ; OTCBB: - ), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular diseases, announced today that the Company has completed recruitment of its Phase I/II clinical study using its lead compound CTCE-9908 with late stage cancer patients. Dosing is expected to be completed by the end of October 2007 with results reported by the end of... (CCNMatthews Press Releases)
Promising New Source Of Stem Cells: Mouse Testes Produce Wide Range Of Tissue Types Sep 25, 2007
If the same can be done with human cells, they say, adult stem cells may be a promising source of new therapies for men, for diseases such as vascular diseases, heart disease, Alzheimer's, Parkinson's, stroke, diabetes, and even cancer. Scientists have had good success in deriving pluripotent stem cell lines -- those with the ability to develop into multiple cell types -- from adult testes cells. (Science Daily)
Stem Cells from Testes Produce Wide Range of Tissue Types Sep 21, 2007
If the same can be done with adult testes stem cells from humans, they may offer a source of new therapies to treat men with health problems such as heart disease, vascular diseases, diabetes, stroke, Parkinson's, Alzheimer's, and even cancer, the researchers said. The study, by Howard Hughes Medical Institute scientists, is published in the Sept. 20 issue of the journal Nature. (MEDLINEplus)
Edwards Lifesciences gift to establish cardiovascular device research UCI, Sep. 12 Sep 13, 2007
The Edwards Lifesciences Center for Advanced Cardiovascular Technology will promote interaction and collaboration among students, faculty members and experts by incorporating both undergraduate and graduate programs related to heart and vascular diseases. The programs will be directed by UCI's Department of Biomedical Engineering, and will involve a variety of other disciplines, including students from the Integrated Nanosystems Research Facility, the California Institute for Telecommunications... (University of California Newswire, CA)
Rising early may be bad for the heart Sep 8, 2007
"Rising early to go to work or exercise might not be beneficial to health, but rather a risk for vascular diseases," said an abstract of the study. Dr V Mohan Kumar, vice-president of the World Federation of Sleep Research and Sleep Medicine Societies, told TOI that an adult needs a minimum of 6-8 hours of sleep everyday. (India Times, India -- Health/Science)
Early risers more likely to have heart problems Sep 7, 2007
"Rising early to go to work or exercise might not be beneficial to health, but rather a risk for vascular diseases," said the study. The study, conducted by researchers from several universities and hospitals in the western Japanese city of Kyoto, revealed a link between wake-up times and a person's cardiovascular condition. (Xinhuanet, China)
Little Shasta Valley rancher honored Sep 6, 2007
He is involved in a project of investigating the variation and opportunities to genetically select cattle for beef products that are more healthful especially as it relates to potential vascular diseases such as heart attacks. His work in this area includes participating as a cooperating producer with his calves. (Mount Shasta News, CA)
ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent Sep 4, 2007
THR-100 is a thrombolytic agent developed for the treatment of acute myocardial infarction (AMI or heart attack) and other vascular diseases, based on its ability to dissolve blood clots ... Desire Collen, CEO of ThromboGenics, commented on today's announcement: "We are pleased that ThromboGenics and Bharat Biotech have successfully completed the technology transfer needed for the production of THR-100. Transfer of biopharmaceutical production technology from one company to another, or from one... (PR Newswire)
Dr. Robbert de Winter to Present Pros and Cons of Drug-Eluting Stents and the Benefits of Using an Alternative Pro-Healing Stent to European Cardiologists Aug 30, 2007
The best recent scientific developments and novel research will be presented to medical professionals who deal with cardiovascular diseases in the course of their professional activity. About OrbusNeich OrbusNeich designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. (PR Newswire)
MRI scans: Diagnostic tool grows in popularity Aug 29, 2007
It is likewise very valuable for the diagnosis of cancer, heart and vascular diseases. Wikipedia says that unlike X-rays and CT scans, MRI does not expose patients to any damaging forms of radiation. (Jakarta Post, Indonesia -- Features)
Q&A with Sandy Feather: Digging deep to protect healthy oak trees from infected ones Aug 25, 2007
Vascular diseases such as oak wilt are easily transmitted from infected trees to healthy ones through such shared tissue. If your neighbor's trees are within 50 feet of your trees, it is likely their roots have grafted together. (Pittsburgh Post-Gazette, PA)
Endologix Completes Enrollment in Powerlink Trial with 34 Millimeter Diameter Infrarenal Cuff Aug 21, 2007
Endologix, Inc. develops and manufactures minimally invasive treatments for vascular diseases. Endologix's Powerlink System is an endoluminal stent graft (ELG) for treating abdominal aortic aneurysms (AAA). (BusinessWire)
160 mln Chinese adults suffer from blood fat abnormality Aug 14, 2007
Cardiovascular diseases, the No. 1 killer for Chinese, causes about 3 million deaths in the country, or 40 percent of the annual deaths number, according to Zhao Dong, director of Beijing's municipal center for the control of heart, lung and vascular diseases. Abnormal blood lipid is one of the main factors causing cardiovascular problems, the expert said. (Xinhuanet, China)
OrbusNeich Expands Global Sales and Marketing Team Jul 30, 2007
OrbusNeich designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. The company's product portfolio includes the Genous Bio-engineered R stent, an antibody-coated device that is the first ever stent to capture a patient's endothelial progenitor cells (EPCs) to accelerate the natural healing process following placement. (PR Newswire)
Ev3 buys FoxHollow for $780M Jul 25, 2007
FoxHollow makes devices to treat arterial blockage, whereas ev3 makes devices to treat vascular diseases. The companies said that the combined company would have a market capitalization of approximately $1. (Twin Cities Business Journal, MN)
Medical Device Companies Announce Merger Jul 23, 2007
Merger plans were announced Sunday by medical device companies based in Minnesota and California that develop and market minimally invasive devices to treat vascular diseases and disorders. Plymouth-based ev3 Inc. and FoxHollow Technologies Inc. of Redwood City, Calif. (WCCO.com, MN)
Drinking may not be so bad, say scientists Jul 11, 2007
Both help in preventing strokes and vascular diseases such as heart disease, and both have been shown to increase cognitive function. Just to give a few examples. (ABC Online)
BMH brings Dr. Yue to city Jul 8, 2007
His interest is not only with cardiac disease, but also peripheral vascular diseases, such as renal arteries, carotid arteries and leg circulation ... Additionally he is board certified in Internal Medicine and Cardiovascular Diseases and has contributed to a variety of prestigious publications since 1989. (DeRidder Beauregard Daily News, LA)
Erectile Dysfunction May 29, 2007
Vascular diseases and diabetes and, in a few cases, hormonal level imbalance, are all examples of physical problems. Within the physical problem category we should also include obesity, alcohol, smoking, the effects of some recreational drugs and some medicines. (Suite101.com)
Chemokine Therapeutics Amends License Agreement With UBC May 24, 2007
VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - May 24, 2007) - Chemokine Therapeutics Corp. ("Chemokine" or the "Company") (TSX: - ; OTCBB: - ), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular diseases, today announced that it has amended certain terms of its license agreement with The University of British Columbia ("UBC") dated September 22, 1999. Under the terms of the license agreement with UBC, Chemokine was required to meet... (CCNMatthews Press Releases)
Urodynamix Cancels Proposed Share Consolidation May 23, 2007
The Company is currently developing NIRS applications for urological conditions in men and women, intra-abdominal hypertension and compartment syndrome, erectile dysfunction and vascular diseases. The Company's disruptive technology has the potential to affect the diagnosis and treatment of more than 200 million people worldwide. (CCNMatthews Press Releases)
Ways to prevent memory loss May 22, 2007
Vascular diseases -- heart disease and stroke -- can contribute to the development and severity of dementia and Alzheimer's disease. Don't smoke or abuse alcohol: Smokers perform worse than nonsmokers in studies of memory and thinking skills. (Akron Beacon Journal, OH -- Living)
OrbusNeich Receives CE Mark Approval for Blazer(TM) Cobalt Chromium Stent, Sapphire(TM) PTCA Dilatation Catheter, Lumina(TM) Guiding Catheter May 21, 2007
" OrbusNeich designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. The company's product portfolio includes the Genous(TM) Bio-engineered R stent, an antibody-coated device that is the first-ever stent to capture a patient's endothelial progenitor cells (EPCs) to accelerate the natural healing process following placement. Other products are stents, balloons and guiding catheters marketed under the names of Blazer, R stent(TM), Sapphire,... (PR Newswire)
Lifewire: More praise for the Mediterranean model May 19, 2007
Its purpose is to evaluate a series of hypotheses about men's health relating nutritional factors to the incidence of serious illnesses, such as cancer, heart disease, and other vascular diseases. The all-male study was designed to complement the all-female Nurses' Health Study, which examines similar hypotheses. (Bend Weekly)
Migraines During Pregnancy Linked To Stroke And Other Vascular Diseases May 3, 2007
Migraines during pregnancy are strongly linked to vascular diseases, such as stroke and heart disease, according to new research. Researchers looked at a national database of nearly 17 million women discharged for pregnancy deliveries from 2000-2003. (Science Daily)
Ev3 to raise $166.25M in secondary offering Apr 22, 2007
Ev3 is a global medical device company focused on catheter-based technologies for the endovascular treatment of vascular diseases and disorders. cwyant@bizjournals. (Twin Cities Business Journal, MN)
Chemokine Therapeutics announces 2006 financial and operating results Apr 17, 2007
TSX: CTI OTCBB: CHKT VANCOUVER, April 16 /PRNewswire-FirstCall/ - Chemokine Therapeutics Corp. (the "Company") (TSX:CTI, OTCBB:CHKT), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular diseases, today announced highlights and the financial and operating results of the year ended December 31, 2006. 2006 Highlights: - Commencement and continued enrollment of subjects to the Phase Ib/II clinical study of CTCE-9908 to assess the safety and... (PR Newswire)
Scientists find major susceptibility genes for Crohn's disease Apr 17, 2007
Founded in 1954, the Montreal Heart Institute is Canada's largest and oldest institution dedicated to research, education and clinical care of cardiovascular diseases ... Its prime focus areas of research are vascular diseases, myocardial function and electrophysiology. (EurekAlert!)
